Home › Funds › WEXFORD CAPITAL LP › NEPH

WEXFORD CAPITAL LP position in NEPH

Nephros Inc · Health Care

WEXFORD CAPITAL LP reported holding 3,600,552 shares of NEPH (Nephros Inc) in its Q2 2026 13F filing — a position valued at US$12.9M, representing 1.64% of its reported portfolio and ranking #10 among its reported holdings. WEXFORD CAPITAL LP has disclosed NEPH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.60M sh
Reported value held$12.85M
Portfolio Weight1.64%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How WEXFORD CAPITAL LP's NEPH position evolved

WEXFORD CAPITAL LP first disclosed a stake in NEPH in Q3 2023 at 3,687,438 shares (US$5.5M). The position peaked in Q4 2025 at 3,617,033 shares, worth US$17.7M. Across 12 filings, WEXFORD CAPITAL LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 3,600,552 shares valued at US$12.9M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.69M $5.46M New
Q4 2023 3.68M $12.74M Hold
Q1 2024 3.60M $7.95M Reduce
Q2 2024 3.60M $7.64M Hold
Q3 2024 3.60M $6.16M Hold
Q4 2024 3.60M $5.28M Hold
Q1 2025 3.60M $6.19M Hold
Q2 2025 3.61M $14.76M Hold
Q3 2025 3.62M $17.11M Hold
Q4 2025 3.62M $17.65M Hold
Q1 2026 3.60M $10.73M Hold
Q2 2026 3.60M $12.85M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NEPH and 13F data

NEPH (Nephros Inc) is a Health Care company. 34 other funds we track also report a position in NEPH — the largest reported positions include Topline Capital Management, LLC (US$1.9M), ELKHORN PARTNERS LIMITED PARTNERSHIP (US$39K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NEPH

All NEPH fund holders →

FAQ

How long has WEXFORD CAPITAL LP held NEPH?

WEXFORD CAPITAL LP has disclosed NEPH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is WEXFORD CAPITAL LP's current position in NEPH?

As of Q2 2026, WEXFORD CAPITAL LP holds 3.60M shares of NEPH (Nephros Inc), valued at $12.85M, representing 1.64% of its reported portfolio and ranking #10.

Has WEXFORD CAPITAL LP been buying or selling NEPH?

In the latest 13F filing (Q2 2026), WEXFORD CAPITAL LP held unchanged its position in NEPH. The position peaked in Q4 2025 at 3.62M shares.

Which other funds hold NEPH?

Other major institutional holders of NEPH include Topline Capital Management, LLC, ELKHORN PARTNERS LIMITED PARTNERSHIP, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.